# Combination of Irreversible Electroporation and Clostridium novyi-NT Bacterial Therapy for Colorectal Liver Metastasis

## TL;DR

A new treatment combining electric pulses and bacteria is proposed to better target hard-to-treat liver tumors in colorectal cancer patients.

## Contribution

Combining irreversible electroporation with C. novyi-NT bacteria offers a novel strategy to target hypoxic tumor regions in colorectal liver metastasis.

## Key findings

- IRE creates hypoxia in tumors, which promotes the growth of C. novyi-NT bacteria in low-oxygen environments.
- The combination of IRE and C. novyi-NT may enhance tumor destruction and stimulate antitumor immunity.
- Advanced imaging and AI can improve treatment planning and monitoring for this combined approach.

## Abstract

Colorectal liver metastasis (CRLM) presents a significant challenge, especially in patients unsuitable for surgery, due to the limited success of the current treatments for targeting the hypoxic tumor regions effectively. This review highlights a promising new strategy combining irreversible electroporation (IRE) and Clostridium novyi-NT (C. novyi-NT) bacterial therapy. IRE ablates tumors and temporarily induces hypoxia, creating an ideal environment for C. novyi-NT, an engineered bacterium that specifically destroys cancer cells in low-oxygen conditions. This synergistic approach aims to enhance tumor destruction and stimulate the immune response. While needing further validation, integrating advanced imaging and artificial intelligence for precise planning, this novel treatment offers a potential breakthrough for CRLM patients.

Colorectal liver metastasis (CRLM) poses a significant challenge in oncology due to its high incidence and poor prognosis in unresectable cases. Current treatments, including surgical resection, systemic chemotherapy, and liver-directed therapies, often fail to effectively target hypoxic tumor regions, which are inherently more resistant to these interventions. This review examines the potential of a novel therapeutic strategy combining irreversible electroporation (IRE) ablation and Clostridium novyi-nontoxic (C. novyi-NT) bacterial therapy. IRE is a non-thermal tumor ablation technique that uses high-voltage electric pulses to create permanent nanopores in cell membranes, leading to cell death while preserving surrounding structures, and is often associated with temporary tumor hypoxia due to disrupted perfusion. C. novyi-NT is an attenuated, anaerobic bacterium engineered to selectively germinate and proliferate in hypoxic tumor regions, resulting in localized tumor cell lysis while sparing healthy, oxygenated tissue. The synergy between IRE-induced hypoxia and hypoxia-sensitive C. novyi-NT may enhance tumor destruction and stimulate systemic antitumor immunity. Furthermore, the integration of advanced imaging and artificial intelligence can support precise treatment planning and real-time monitoring. This integrated approach holds promise for improving outcomes in patients with CRLM, though further preclinical and clinical validation is needed.